Shewring G, Smith B R
Clin Endocrinol (Oxf). 1982 Oct;17(4):409-17. doi: 10.1111/j.1365-2265.1982.tb01607.x.
An improved receptor assay for TSH receptor antibodies is described in which detergent-solubilized TSH receptors and 125I-labelled TSH are used. Normal human serum and immunoglobulin concentrates from normal serum showed little effect on the interaction between labelled TSH and detergent-solubilized receptors whereas immunoglobulin concentrates from some Graves sera caused marked inhibition of TSH binding. Precipitation with polyethylene glycol was the most convenient way of preparing immunoglobulin concentrates and using this technique the assay could be completed in a few hours. The coefficient of inter assay variation at 51% inhibition of labelled TSH binding was 3.7% and analysis of serum samples from patients with Graves' disease (n = 42), Hashimoto's disease (n = 26), multinodular goitre (n = 9), rheumatoid arthritis (n = 10) and normal donors (n = 35) suggested that the assay could detect TSH receptor antibodies in about 80% of patients (treated and untreated) with Graves' disease.
本文描述了一种改进的促甲状腺激素(TSH)受体抗体检测方法,该方法使用了去污剂溶解的TSH受体和¹²⁵I标记的TSH。正常人血清和来自正常血清的免疫球蛋白浓缩物对标记的TSH与去污剂溶解的受体之间的相互作用影响很小,而来自一些格雷夫斯病(Graves病)患者血清的免疫球蛋白浓缩物则会显著抑制TSH的结合。用聚乙二醇沉淀是制备免疫球蛋白浓缩物最方便的方法,使用该技术检测可在数小时内完成。在标记的TSH结合抑制率为51%时,批间变异系数为3.7%。对格雷夫斯病患者(n = 42)、桥本氏病患者(n = 26)、多结节性甲状腺肿患者(n = 9)、类风湿性关节炎患者(n = 10)和正常献血者(n = 35)的血清样本分析表明,该检测方法可在约80%的格雷夫斯病患者(无论是否接受治疗)中检测到TSH受体抗体。